Jianjun Gao
0000-0001-6138-4472
University of Texas MD Anderson Cancer Center
6 papers found
Refreshing results…
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma
Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer
Tumor-associated nonmyelinating Schwann cell–expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma
Missing publications? Search for publications with a matching author name.